News

US-based Merck buys UK’s Verona Pharma for $10bn

Big pharma is investing heavily in late-stage biotech, focusing on approved or near-market treatments in high-need areas like respiratory disease, as companies prepare for future revenue drops from older high-earning medicines.

July 17, 2025

Interview with Ash Ramachandran, Founder of Sapyen, on the untapped male fertility diagnostics market

Sapyen, an online male fertility diagnostics company based in Melbourne, with operations across the UK, Europe, the US, and Australia, is trying to fix that. The company has developed a home testing kit that extends the viability of semen samples, making it easier for men to get tested without needing to visit a clinic. Ash Ramachandran, the founder of Sapyen, spoke to HBI about the fertility landscape, investment trends, and how the company is helping men access testing more easily.

July 17, 2025

European healthcare real estate investment bounces back, bolstered by US investors

The bounce-back of investment into European healthcare real estate that many investors and analysts in the sector were predicting for 2025 looks to be materialising. Data from multiple advisory firms shows a 50% increase in Q1 2025 compared to Q1 2024.

July 17, 2025

Indira IVF confidentially refiles IPO amid rising investor interest in India’s fertility sector

India’s assisted reproductive technology sector is drawing strong interest from investors. Money is flowing into fertility providers as demand grows, and new technologies develop.

July 17, 2025

Romanian Competition Council reviews Mehiläinen’s acquisition of Regina Maria and MediGroup

In April 2025, HBI reported that Mehiläinen, Finland’s largest private healthcare group, backed by Luxembourg-based private equity firm CVC Capital Partners, had bought Romania’s Regina Maria and Serbia’s MediGroup from private equity firm MidEuropa. Now, Romania’s Competition Council has officially opened an investigation to see if the deal might reduce competition in the local healthcare market. This review is an important regulatory step that could affect whether the acquisition is finally approved and under what conditions.

July 17, 2025

Advent sells Donte to OTPP for €1bn

Donte Group (formerly Vitaldent), Spain’s largest dental chain, has been sold by US PE firm Advent to Canadian pension fund Ontario Teachers' Pension Plan (OTPP), for €1 billion. OTPP tells us the plan is to continue growing the group within the Spanish dental market organically, and work with Donte to consider “selective” M&A opportunities.

July 17, 2025

Aedifica shareholders back merger with Cofinimmo

Aedifica and Cofinimmo, two of Europe’s biggest listed healthcare-focused REITs, are one step closer to merging and becoming Europe’s largest healthcare real estate investor, after a majority of Aedifica’s shareholders gave their approval to the board’s proposal to acquire Cofinimmo.

July 15, 2025

FREE BLOG How will EU tariff negotiations affect pharma prices?

In the face of Trump’s impending tariffs, Europe has been mulling over the best course of action to protect its industries.

July 10, 2025

China bans EU medical device imports in tit-for-tat move

China has responded tit-for-tat against the EU’s decision to ban China from selling medical devices to EU governments, barring EU medical device producers from selling to Chinese government hospitals.

July 10, 2025

What does the NHS 10-year plan mean for the UK’s private healthcare sector? HBI speaks to industry leaders

The UK Government’s 10 Year Plan for the NHS is ambitious, but experts say it will only work if it's well delivered and built on strong partnerships. For the private healthcare sector, there are clear opportunities to get involved, especially in areas like diagnostics, digital tools, and community care.

July 10, 2025

Older posts

Newer posts

News

July 17, 2025

July 17, 2025

July 17, 2025

July 17, 2025

July 17, 2025

July 17, 2025

July 15, 2025

July 10, 2025

July 10, 2025

July 10, 2025

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.